Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11998571
Pharmaceutical composition comprising stem cell-conditioned medium and exosome isolated therefrom as active ingredient for prevention or treatment of ocular disease
granted -
US 11998528
Non-sedating dexmedetomidine treatment regimens
granted -
US 11999693
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
granted -
US 11993658
Anti-BCMA antibodies and treatment methods
granted -
US 11986515
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
granted -
US 11986534
Treatment of anthrax with pegylated capsule-degrading enzyme
granted -
US 11981921
TIL expansion processes using specific cytokine combinations and/or AKTi treatment
granted -
US 11980636
Treatment of hematological disorders
granted -
US 11980645
Bile acids and use in disease treatment
granted -
US 11981912
Adeno associated virus vectors for the treatment of hunter disease
granted -
US 11975056
AADC polynucleotides for the treatment of Parkinson's disease
granted -
US 11975046
Medical use of interferon-lambda for the treatment of fibrosis
granted -
US 11975016
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment
granted -
US 11975003
Methods and compositions for treatment of Zika virus infection
granted -
US 11969499
Hydrogel delivery of sting immunotherapy for treatment cancer
granted -
US 11969511
Methods and compositions for antimicrobial treatment
granted -
US 11964000
Cancer treatment methods using nanofiber stabilized growth factors
granted -
US 11957684
Treatment of heavy menstrual bleeding associated with uterine fibroids
granted -
US 11957677
Cancer treatment using FGFR inhibitors and PLK1 inhibitors
granted -
US 11952330
Antibiotic ammonium compounds and methods for the treatment of bacterial infections
granted -
US 11951212
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted -
US 11945781
Compounds for the treatment of acute and chronic kidney disease
granted -
US 11944666
Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11938150
Treatment of neurodegenerative disease with sodium chlorite
granted